Osaka - Peach Aviation Limited ('Peach' Representative Director and CEO: Takeaki Mori) has announced an extension to the target period for its 'post-antigen test domestic flight trial project' (hereafter, 'this Project'), which enables passengers to take domestic flights after

passing a pre-boarding antigen test.

This Project was originally implemented for passengers boarding between November 20 and December 19 at a cost to the tested recipients of JPY3,000 (excluding tax), but this test period is now being extended until March 31, 2021 due to substantial demand for the year-end and New Year holiday period and onward.

Applications for tests are accepted until March 25, 2021. The two target routes - which have not changed - cover flights departing Kansai Airport for Miyazaki and Amami.

We are partnering with two clinics, namely Utsubo Garden Clinic (Osaka City) and Morikawa Clinic

(Amagasaki City, Hyogo prefecture). Those who would like to be tested must make an appointment

and visit one of the clinics at least 5 days prior to the flight. Please check the clinic websites to see

when they are closed over the year-end and New Year holiday period.

Together with our customers, Peach will contribute to the recovery of the Japanese economy

by building new travel styles around the theme of 'Bridging your Sky,' while continuing its safe operations and thorough measures to prevent the Covid-19 infection.

Special website page for 'New Coronavirus Antigen Test Support Option' https://www.flypeach.com/mp/others/antigentest_support

*Japanese only

Ensuring safe travel with peace of mind

Optional support for

Covid-19 antigen tests

For flights departing Osaka (Kansai) for Miyazaki & Amami

Launch of trial project to take domestic flights after antigen test

https://corporate.flypeach.com/cms/wp-content/uploads/2020/11/201113-Press-Release-E.pdf

(Partner clinics)

Utsubo Garden Clinic https://utsubo-garden-clinic.com/

Morikawa Clinic https://www.morikawa-naika-clinic.com

(C) 2020 Electronic News Publishing, source ENP Newswire